Overall, our study demonstrates the importance of CDK4/6–DUB3 axis in regulating breast cancer metastasis and provides a rationale for potential therapeutic interventions in the treatment of breast cancer metastasis. This evidence concerns the gene USP17L2 and breast cancer.